Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion: Complete Statistical AnalysisIndependent statistical analysis of Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients: Complete Statistical AnalysisIndependent statistical analysis of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01823510).
- TICL-PASIndependent statistical analysis of STAAR Visian Toric ICL Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04516772).
- TICSIndependent statistical analysis of Tick-borne Illness and Clothing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01454414).
- TICSIndependent statistical analysis of Transcranial Magnetic Stimulation for Children With Tourette's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02356003).
- TICTACIndependent statistical analysis of Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TIDEIndependent statistical analysis of Thiazolidinedione Intervention With Vitamin D Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00879970).
- TIDE-asthmaIndependent statistical analysis of Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TIGER KidsIndependent statistical analysis of Translational Investigation of Growth and Everyday Routines in Kids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02784509).
- TIGHTIndependent statistical analysis of Time in Glucose Hospital Target: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05135676).
- TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TiLLTIndependent statistical analysis of Transmitted Light Tissue Thickness Analysis (TiLTT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02749201).
- Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TIMIndependent statistical analysis of Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02043548).
- Time Course Adaptations Using Deuterated Creatine (D3Cr) Method: Complete Statistical AnalysisIndependent statistical analysis of Time Course Adaptations Using Deuterated Creatine (D3Cr) Method: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03573583).
- Time Restricted Eating Pilot – Bariatrics: Complete Statistical AnalysisIndependent statistical analysis of Time Restricted Eating Pilot - Bariatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04006366).
- Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Time-restricted Eating in Cancer Survivorship: A Single-arm Feasibility Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243512).
- Time-Restricted Eating to Address Persistent Cancer-Related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Time-Restricted Eating to Address Persistent Cancer-Related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256888).
- TimeLEAdIndependent statistical analysis of Time Limited Eating in Adolescents (Time LEAd): a Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03954223).
- Timing of Antibiotic Prophylaxis for Cesarean Deliveries: Complete Statistical AnalysisIndependent statistical analysis of Timing of Antibiotic Prophylaxis for Cesarean Deliveries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805545).
- Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: Complete Statistical AnalysisIndependent statistical analysis of Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Timing of Caloric Intake, Diet-induced Thermogenesis and Hormonal Pattern: Complete Statistical AnalysisIndependent statistical analysis of Timing of Caloric Intake, Diet-induced Thermogenesis and Hormonal Pattern: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02343380).
- Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery: Complete Statistical AnalysisIndependent statistical analysis of Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03048682).
- TINTINIndependent statistical analysis of Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tiotropium / Respimat One Year Study in COPD.: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium / Respimat One Year Study in COPD.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00387088).
- Tiotropium Bromide in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium Bromide in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01179347).
- Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tiotropium/Salmeterol Inhalation Powder in COPD: Complete Statistical AnalysisIndependent statistical analysis of Tiotropium/Salmeterol Inhalation Powder in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00668772).
- TIPIndependent statistical analysis of Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05113277).
- TIPIndependent statistical analysis of The Identity Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03772522).
- Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082810).
- Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial: primary endpoint results, effect estimate with confidence…
- Tipifarnib in Subjects With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Subjects With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02779777).
- Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082888).
- TIPPIIndependent statistical analysis of TB Innovation Project: A Pre- and Post- Implementation Assessment (TIPPI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03948698).
- Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: Complete Statistical AnalysisIndependent statistical analysis of Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00530920).
- TIPSIndependent statistical analysis of Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection: Complete Statistical AnalysisIndependent statistical analysis of Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TIRCON-EXTIndependent statistical analysis of Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02174848).
- TISIndependent statistical analysis of Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: primary endpoint results, effect estimate with confidence…
- Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: Complete Statistical AnalysisIndependent statistical analysis of Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TitAINIndependent statistical analysis of A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TITANIndependent statistical analysis of Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP): primary endpoint results, effect estimate with confidence interval,…
- Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification: Complete Statistical AnalysisIndependent statistical analysis of Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TITREIndependent statistical analysis of Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710866).
- TIV and High Dose TIV in Subjects With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of TIV and High Dose TIV in Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01436370).
- TIVAIndependent statistical analysis of Targeting Inflammation to Treat Cardiovascular Aging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01775865).
- Tivantinib in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tivantinib in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519414).
- Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with…